MarkArthurPrestonMD

Urology • Boston, MA

Surgical Oncology

Assistant Professor of Surgery - Harvard Medical School, Brigham and Women’s Hospital

Join to view full profile

Dr. Preston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Preston's full profile

Already have an account?

Office
36 Hancock St
Apt 5B
Boston, MA 02114
Phone+1 617-650-7798

Education & Training

Massachusetts General HospitalFellowship, Urologic Surgical Oncology, 2011 - 2014
Harvard School of Public HealthMasters of Public Health, 2011 - 2014
University of Ottawa Faculty of MedicineClass of 2006

Certifications & Licensure

MA State Medical License 2011 - 2026
ME State Medical License 2020 - 2026
RI State Medical License 2022 - 2026
NH State Medical License 2023 - 2025
American Board of Urology Urology

Clinical Trials

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer Start of enrollment: 2016 Nov 01
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

1 citations
Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer.
Mark A Preston, Ramin Ebrahimi, Agnes Hong, Priyanka Bobbili, Raj Desai
Urologic Oncology. 2024-12-01
Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer.
William Paul Skelton 4th, Jack Masur, Jonathan Thomas, Parvaneh Fallah, Rohit K Jain
Clinical Genitourinary Cancer. 2024-10-01
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.
Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Drupad Annapureddy, Jeffrey Howard
BJU International. 2024-08-25

Lectures

81st Annual Meeting of New England Section of the American Urological Association
New England Section of the American Urological Association( NE-AUA ), Boston, Massachusetts - 9/6/2012

Press Mentions

In Black Men, Baseline Screening in Midlife Strongly Predicts Aggressive Prostate CancerOctober 10th, 2018
PSA Test Best at Predicting Lethal Prostate Cancer, Study SaysJune 14th, 2016
A Smarter Screening Strategy for Prostate Cancer Can Predict MortalityJune 14th, 2016
Join now to see all